Metraipolis › archive › dc_71c6ebd08d0e
T cell receptor-engineered T cells targeting the TP53R248Q neoantigen elicit antitumor effects in human cancer models — Europe PMC PMID:41528883
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/41528883
- DOI
- 10.1172/jci196613
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-06T20:39:42.086Z
- SHA-256 of the archived text
90388d33f19dac2af29380750ee9ce68cbd39be0b4b2486cfac4b0db77507375- Stable URL of this page
https://metraipolis.com/documento/dc_71c6ebd08d0e
How to cite
T cell receptor-engineered T cells targeting the TP53R248Q neoantigen elicit antitumor effects in human cancer models — Europe PMC PMID:41528883 — Europe PMC (en), https://europepmc.org/article/MED/41528883 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_71c6ebd08d0e (Metraipolis archive dc_71c6ebd08d0e, sha256 90388d33f19dac2af29380750ee9ce68cbd39be0b4b2486cfac4b0db77507375)
BibTeX
@misc{dc71c6ebd08d0e,
title = {T cell receptor-engineered T cells targeting the TP53R248Q neoantigen elicit antitumor effects in human cancer models — Europe PMC PMID:41528883},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/41528883},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_71c6ebd08d0e; sha256 90388d33f19dac2af29380750ee9ce68cbd39be0b4b2486cfac4b0db77507375},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41528883. Agents can read the archived copy with the MCP tool read_document.